Publications by authors named "Mark Claassen"

Claim this Profile
P
Prediction of Hepatocellular Carcinoma and Liver-related Events in Anti-hepatitis D Virus-positive Individuals.
Lesley A Patmore, Michelle Spaan, Kosh Agarwal, Özgür M Koc, Hans Blokzijl, Mark Claassen

Clin Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.
Lesley A Patmore, Ivana Carey, Jordan J Feld, Willem P Brouwer, Keyur Patel, Mark A A Claassen

Aliment Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Socio-Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B.
Clémence Ramier, Anders Boyd, Colette Smit, Rosan van Zoest, Mark A A Claassen

Liver Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical Trials.
Edo J Dongelmans, Jordan J Feld, André Boonstra, Sylvia M Brakenhoff, David Wong, Mark Claassen

Aliment Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022.
Anders Boyd, Colette Smit, Annemiek A van der Eijk, Hans Zaaijer, Bart Ja Rijnders, Mark Aa Claassen

Euro Surveill· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.
Marta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, Robin Soetekouw, Steven F L van Lelyveld, Mark A A Claassen

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
Lesley A Patmore, Kirsi M A van Eekhout, Maria Buti, Özgur M Koc, Kosh Agarwal, Mark A A Claassen

J Hepatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study.
Sylvia M Brakenhoff, Mark Claassen, Pieter Honkoop, Robert J de Knegt, Annemiek A van der Eijk

Clin Res Hepatol Gastroenterol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.
Arjen J Stam, Ninée V E J Buchholtz, Wouter F W Bierman, Reinout van Crevel, Andy I M Hoepelman, Mark A A Claassen

Viruses· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to use quality indicators for antimicrobial stewardship in your hospital: a practical example on outpatient parenteral antimicrobial therapy.
Ralf Stemkens, Jeroen A Schouten, Sophie A M van Kessel, Reinier P Akkermans, Denise S C Telgt, Mark A A Claassen

Clin Microbiol Infect· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals.
Stephanie Popping, Lize Cuypers, Mark A A Claassen, Guido E van den Berk, Anja De Weggheleire

Viruses· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short Communication: Prolonged COVID-19 Infection in a Patient with Newly Diagnosed HIV/AIDS.
Tom Ketels, Jet Gisolf, Mark Claassen, Caroline Swanink, Ellen van Lochem

AIDS Res Hum Retroviruses· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
Karin Leber, Hans-Martin J M M B Otten, Dees P M Brandjes, Mark A A Claassen, Fanny N Lauw

Eur J Cancer Care (Engl)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study.
Colette Smit, Anders Boyd, Bart J A Rijnders, Thijs J W van de Laar, Eliane M Leyten, Mark A A Claassen

Lancet HIV· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission of NS5A-Inhibitor Resistance-Associated Substitutions Among Men Who Have Sex With Men Recently Infected with Hepatitis C Virus Genotype 1a.
Stephanie Popping, Rosanne Verwijs, Lize Cuypers, Mark A Claassen, Guido E van den Berk

Clin Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autochthonous Human Case of Seoul Virus Infection, the Netherlands.
Caroline Swanink, Johan Reimerink, Jet Gisolf, Ankje de Vries, Mark Claassen

Emerg Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.
Anne Boerekamps, Anja De Weggheleire, Guido E van den Berk, Fanny N Lauw, Mark A A Claassen

Lancet Gastroenterol Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia.
Maud B P A Ariaans, Elisabeth A Roovers, Mark A A Claassen, Robert-Jan Hassing, Caroline M A Swanink

Eur J Clin Microbiol Infect Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Anne Boerekamps, Guido E van den Berk, Fanny N Lauw, Eliane M Leyten, Marjo E van Kasteren, Mark A Claassen

Clin Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of latent tuberculous infection among HIV-infected patients in a Dutch out-patient clinic.
Petra van Bentum, Caroline M A Swanink, Ellen G van Lochem, Mark A A Claassen, Elisabeth H Gisolf

Int J Tuberc Lung Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.
Boris J B Beudeker, Gertine W van Oord, Joop E Arends, Julian Schulze Zur Wiesch, Marieke S van der Heide, Mark A A Claassen

Liver Int· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls.
Lennert van den Dries, Mark A A Claassen, Zwier M A Groothuismink, Eric van Gorp, Andre Boonstra

Virology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Case | A patient with antineutrophil cytoplasmic antibody-positive vasculitis on treatment with fever and leucopenia.
Maya Kemps, Jacobien C Verhave, Mark A A Claassen, Janneke Ruinemans-Koerts, Ellen van der Spek

Kidney Int· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
Michelle Spaan, Sebastiaan J Hullegie, Boris J B Beudeker, Kim Kreefft, Gertine W van Oord, Mark A A Claassen

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
Sebastiaan J Hullegie, Joop E A Arends, Zwier M A Groothuismink, Suzan D Pas, Bart J A Rijnders, Mark A A Claassen

J Gen Virol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis